245 related articles for article (PubMed ID: 15940441)
1. Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy.
Pohl T; Kupatt C; Steinbeck G; Boekstegers P
Z Kardiol; 2005 Jun; 94(6):405-10. PubMed ID: 15940441
[TBL] [Abstract][Full Text] [Related]
2. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
[TBL] [Abstract][Full Text] [Related]
3. Coronary stenting with the sirolimus-eluting stent in patients with restenosis after intracoronary brachytherapy: results from the prospective multicentre German Cypher Stent Registry.
Zahn R; Hamm CW; Zeymer U; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA; Pfannebecker T; Senges J
Clin Res Cardiol; 2010 Feb; 99(2):99-106. PubMed ID: 19882098
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN Study.
Brüggenjürgen B; McBride D; Bode C; Hamm CW; Kuck KH; Willich SN
Herz; 2007 Dec; 32(8):650-5. PubMed ID: 18060612
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
[TBL] [Abstract][Full Text] [Related]
8. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
9. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
[TBL] [Abstract][Full Text] [Related]
10. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW
Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis.
Le Feuvre C; Montalescot G; Rosey G; Collet JP; Beygui F; Choussat R; Gelft G; Monségu J; Ohanessian A; Spaulding C; Drobinski G; Metzger JP
Int J Cardiol; 2006 May; 109(2):207-12. PubMed ID: 15993962
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
Alli OO; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; Holmes DR;
Am Heart J; 2012 Mar; 163(3):438-45. PubMed ID: 22424015
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
[TBL] [Abstract][Full Text] [Related]
16. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of sirolimus-eluting stent implantation for in-stent restenosis of the unprotected left main coronary artery.
Kim HS; Kim YH; Lee SW; Park DW; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2008 Feb; 124(1):118-20. PubMed ID: 17383034
[TBL] [Abstract][Full Text] [Related]
18. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
[TBL] [Abstract][Full Text] [Related]
19. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis.
Kim YH; Lee BK; Park DW; Park KH; Choi BR; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Dec; 98(11):1451-4. PubMed ID: 17126648
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial.
Wiemer M; König A; Rieber J; Sohn HY; Leibig M; Theisen K; Klauss V; Langer C; Lindner O; Horstkotte D; Schiele TM
EuroIntervention; 2011 Jan; 6(6):687-94. PubMed ID: 21205590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
